These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31425747)

  • 1. Alzheimer's disease-like pathology-triggered oxidative stress, alterations in monoamines levels, and structural damage of locus coeruleus neurons are partially recovered by a mix of proteoglycans of embryonic genesis.
    Aghajanov M; Chavushyan V; Matinyan S; Danielyan M; Yenkoyan K
    Neurochem Int; 2019 Dec; 131():104531. PubMed ID: 31425747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of monoamines in the development of Alzheimer's disease and neuroprotective effect of a proline rich polypeptide.
    Yenkoyan K; Fereshetyan K; Matinyan S; Chavushyan V; Aghajanov M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():76-82. PubMed ID: 29782957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonic proteoglycans regulate monoamines in the rat frontal cortex and hippocampus in Alzheimer's disease-like pathology.
    Chavushyan V; Matinyan S; Danielyan M; Aghajanov M; Yenkoyan K
    Neurochem Int; 2020 Nov; 140():104838. PubMed ID: 32853753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Involvement of Insulin-Like Growth Factor 1 and Nerve Growth Factor in Alzheimer's Disease-Like Pathology and Survival Role of the Mix of Embryonic Proteoglycans: Electrophysiological Fingerprint, Structural Changes and Regulatory Effects on Neurotrophins.
    Aghajanov M; Matinyan S; Chavushyan V; Danielyan M; Karapetyan G; Mirumyan M; Fereshetyan K; Harutyunyan H; Yenkoyan K
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
    Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
    Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoaminergic neuropathology in Alzheimer's disease.
    Šimić G; Babić Leko M; Wray S; Harrington CR; Delalle I; Jovanov-Milošević N; Bažadona D; Buée L; de Silva R; Di Giovanni G; Wischik CM; Hof PR
    Prog Neurobiol; 2017 Apr; 151():101-138. PubMed ID: 27084356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An experimental model of Braak's pretangle proposal for the origin of Alzheimer's disease: the role of locus coeruleus in early symptom development.
    Ghosh A; Torraville SE; Mukherjee B; Walling SG; Martin GM; Harley CW; Yuan Q
    Alzheimers Res Ther; 2019 Jul; 11(1):59. PubMed ID: 31266535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hemilabyrinthectomy on monoamine metabolism in the medial vestibular nucleus, locus coeruleus, and other brainstem nuclei of albino and pigmented rats.
    Cransac H; Peyrin L; Farhat F; Cottet-Emard JM; Pequignot JM; Reber A
    J Vestib Res; 1996; 6(4):243-53. PubMed ID: 8839821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging.
    Satoh A; Iijima KM
    Brain Res; 2019 Jan; 1702():17-28. PubMed ID: 29274876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.
    Ádori C; Glück L; Barde S; Yoshitake T; Kovacs GG; Mulder J; Maglóczky Z; Havas L; Bölcskei K; Mitsios N; Uhlén M; Szolcsányi J; Kehr J; Rönnbäck A; Schwartz T; Rehfeld JF; Harkany T; Palkovits M; Schulz S; Hökfelt T
    Acta Neuropathol; 2015 Apr; 129(4):541-63. PubMed ID: 25676386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus.
    Chalermpalanupap T; Weinshenker D; Rorabaugh JM
    Neural Plast; 2017; 2017():7829507. PubMed ID: 29038736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments.
    Mahaman YAR; Huang F; Wu M; Wang Y; Wei Z; Bao J; Salissou MTM; Ke D; Wang Q; Liu R; Wang JZ; Zhang B; Chen D; Wang X
    J Alzheimers Dis; 2018; 63(3):1141-1159. PubMed ID: 29710724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Populations of Human Locus Ceruleus Neurons Contain Heavy Metals or Hyperphosphorylated Tau: Implications for Amyloid-β and Tau Pathology in Alzheimer's Disease.
    Pamphlett R; Kum Jew S
    J Alzheimers Dis; 2015; 45(2):437-47. PubMed ID: 25547633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer's disease.
    Khan KM; Balasubramanian N; Gaudencio G; Wang R; Selvakumar GP; Kolling L; Pierson S; Tadinada SM; Abel T; Hefti M; Marcinkiewcz CA
    Acta Neuropathol Commun; 2023 Apr; 11(1):57. PubMed ID: 37009893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative propagation of assembled human Tau from Alzheimer's disease brain in microfluidic neuronal cultures.
    Katsikoudi A; Ficulle E; Cavallini A; Sharman G; Guyot A; Zagnoni M; Eastwood BJ; Hutton M; Bose S
    J Biol Chem; 2020 Sep; 295(37):13079-13093. PubMed ID: 32699110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.
    Feinstein DL; Kalinin S; Braun D
    J Neurochem; 2016 Oct; 139 Suppl 2():154-178. PubMed ID: 26968403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CART peptide activates the Nrf2/HO-1 antioxidant pathway and protects hippocampal neurons in a rat model of Alzheimer's disease.
    Jiao W; Wang Y; Kong L; Ou-Yang T; Meng Q; Fu Q; Hu Z
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1016-1022. PubMed ID: 29777699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.